Literature DB >> 17932336

Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.

Dean E Brenner, Daniel P Normolle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17932336     DOI： 10.1158/1055-9965.EPI-07-2619

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  16 in total

1.  Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.

Authors:  Beate Pesch; Dirk Taeger; Georg Johnen; Katarzyna Gawrych; Nadine Bonberg; Christian Schwentner; Harald Wellhäusser; Matthias Kluckert; Gabriele Leng; Michael Nasterlack; Yair Lotan; Arnulf Stenzl; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2013-10-16       Impact factor: 3.015

Review 2.  Proteomics and biomarkers in clinical trials for drug development.

Authors:  Jung-min Lee; Jasmine J Han; Gary Altwerger; Elise C Kohn
Journal:  J Proteomics       Date:  2011-05-04       Impact factor: 4.044

3.  A novel biomarker protein panel for lung cancer, a promising first step.

Authors:  Camilo Molina-Romero; Edgar Vergara; Oscar Arrieta
Journal:  Transl Lung Cancer Res       Date:  2018-12

Review 4.  New paradigms in translational science research in cancer biomarkers.

Authors:  Paul D Wagner; Sudhir Srivastava
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

Review 5.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

Review 6.  OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.

Authors:  V B Kraus; F J Blanco; M Englund; Y Henrotin; L S Lohmander; E Losina; P Önnerfjord; S Persiani
Journal:  Osteoarthritis Cartilage       Date:  2015-05       Impact factor: 6.576

Review 7.  Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis.

Authors:  Cheng-Jeng Tai; Chung-Huei Hsu; Shing-Chuan Shen; Woan-Ruoh Lee; Ming-Chung Jiang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-11

Review 8.  Molecular signatures from omics data: from chaos to consensus.

Authors:  Jaeyun Sung; Yuliang Wang; Sriram Chandrasekaran; Daniela M Witten; Nathan D Price
Journal:  Biotechnol J       Date:  2012-04-23       Impact factor: 4.677

9.  Measuring the combinatorial expression of solute transporters and metalloproteinases transcripts in colorectal cancer.

Authors:  Caroline A Kerr; Robert Dunne; Barney M Hines; Michelle Zucker; Leah Cosgrove; Andrew Ruszkiewicz; Trevor Lockett; Richard Head
Journal:  BMC Res Notes       Date:  2009-08-19

10.  Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.

Authors:  Margaret S Pepe; Ziding Feng; Holly Janes; Patrick M Bossuyt; John D Potter
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.